Literature DB >> 23314380

miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44.

Haien Zhao1, Baoan Ma, Yucai Wang, Tao Han, Lianhe Zheng, Cong Sun, Tao Liu, Yinglong Zhang, Xiuchun Qiu, Qingyu Fan.   

Abstract

Osteosarcoma is the most common type of malignant bone tumor in children and adolescents and approximately 30% of patients develop lung metastasis, which is the leading cause of mortality. In this study, we investigated the role of miR-34a in the invasion and metastasis of osteosarcoma cells by examining its expression level and functional pattern in these cells. miR-34a mimics were transfected into the highly metastatic subline, F5M2, and into the F4 subline with low metastatic potential of the paired human osteosarcoma cell line, SOSP‑9607. Cell viability patterns, cell migration and alterations in gene expression levels were assessed by real-time PCR, and changes in protein levels were assessed by immunocytochemistry and western blot analysis. The ectopic overexpression of miR-34a significantly inhibited the migration and invasive ability of osteosarcoma cells by repressing the expression of CD44. These data suggest that miR-34a plays a tumor suppressor role in the metastasis of osteosarcoma cells by repressing the expression of CD44. Of note, studies have also suggested that the CD44 protein correlates with the metastatic potential of several malignant tumors. Therefore, it can be concluded that through the inhibition of CD44 expression levels, miR-34a plays a significant role in the migration and invasion of osteosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314380     DOI: 10.3892/or.2013.2234

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  31 in total

1.  Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

Authors:  Yong Zhao; Mei-Juan Tu; Yi-Feng Yu; Wei-Peng Wang; Qiu-Xia Chen; Jing-Xin Qiu; Ai-Xi Yu; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2015-10-27       Impact factor: 5.858

2.  MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.

Authors:  Linli Tian; Minghua Li; Jingchun Ge; Yan Guo; Yanan Sun; Ming Liu; Hui Xiao
Journal:  Tumour Biol       Date:  2014-04-01

Review 3.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

4.  Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.

Authors:  Yanchen Chu; Xiaoli Hu; Guangfeng Wang; Zhijie Wang; Yanjin Wang
Journal:  Oncol Lett       Date:  2019-04-01       Impact factor: 2.967

5.  MicroRNA-433 regulates apoptosis by targeting PDCD4 in human osteosarcoma cells.

Authors:  Yinghua Sun; Fuchao Wang; Li Wang; Zhaode Jiao; Jun Fang; Jianmin Li
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

6.  The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.

Authors:  Ji Hyung Hong; Kang San Roh; Sung-Suk Suh; Sukchan Lee; Sook Whan Sung; Jae Kil Park; Jae Ho Byun; Jin Hyoung Kang
Journal:  Tumour Biol       Date:  2015-06-25

7.  VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma.

Authors:  Dong Zhao; Peng Jia; Wenliang Wang; Guangling Zhang
Journal:  Mol Cell Biochem       Date:  2014-11-11       Impact factor: 3.396

8.  MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.

Authors:  Jianhui Zuo; Kechao Zhu; Yunhai Wang; Zaicheng Yu
Journal:  Mol Cell Biochem       Date:  2017-11-01       Impact factor: 3.396

Review 9.  Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.

Authors:  Zhimin Yang; Tang Liu; Xiaolei Ren; Mei Yang; Chao Tu; Zhihong Li
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

10.  Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF.

Authors:  Danhua Zhang; Jianping Zhou; Ming Dong
Journal:  Dig Dis Sci       Date:  2013-12-27       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.